Novel Therapeutic Interventions and Drug Targets for Treatment of Cancer

Dear Colleagues,

This Special Issue centers on the state-of-the-art healing modalities and more safe and efficient drug targets for improved cancer care. Given that cancer is still a significant health menace globally, the development of enhanced and less harmful therapeutic approaches is crucial for the continued fight against this disease. As a result, this Special Issue calls for publications focusing on, but not limited to, novel strategies to address cancer disparities, including targeted treatment modalities, innovative immunology prognostic and potential markers, gene editing, and personalized medicinal methods.

We particularly encourage submissions that detail the discovery and validation of novel drug targets, advancements in molecular and cellular mechanisms of action, and clinical outcomes of recent therapeutic interventions. Research articles, reviews, and case studies that provide insights into the translational potential of preclinical findings are also welcome. Additionally, discussions on the challenges of drug resistance, side effects, and patient-specific treatment plans are of great interest.

This Special Issue aims to gather a collection of high-quality research articles and reviews that will not only inform the scientific community but also foster the development of novel strategies for cancer therapy. By bringing together researchers from diverse fields, we hope to facilitate a comprehensive dialogue on emerging trends and future directions in cancer treatment. Contributions are expected to adhere to rigorous scientific standards and present novel insights that could pave the way for next-generation cancer therapies.

Dr. Adilson Kleber Ferreira
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• drug targets
• innovative immunology prognostic
• potential markers
• gene editing
• personalized medicinal methods
• drug resistance